series-a
Stage
2020
Founded
1
Investors
About
Ignis Therapeutics is a biotechnology company founded in late 2020 that focuses on developing innovative treatments for major brain diseases including epilepsy, excessive daytime sleepiness, insomnia, Parkinson's disease, schizophrenia, and depression, with a current pipeline of 20 products.
Explore Ignis Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.